Trial Profile
Atomoxetine effects on the urine dihydroxyphenylglycol to norepinephrine ratio in children with attention-deficit hyperactivity disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2011
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company; Lilly Research Centre
- 26 Mar 2011 New trial record